Alnylam Pharmaceuticals, Inc. (ALNY)

369.76 -1.15 (-0.31%) USD  |  NASDAQ  |  Jan 13, 10:58
More

Alnylam Pharmaceuticals EBITDA (Per Share Quarterly)

EBITDA (Per Share Quarterly) Chart

View EBITDA (Per Share Quarterly) for ALNY.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EBITDA (Per Share Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EBITDA Definition

View EBITDA Definition
Start Trial

EBITDA is an abbreviation for earnings before interest, taxes, depreciation, and amortization.

Read full definition.

EBITDA (Per Share Quarterly) Range, Past 5 Years

View EBITDA (Per Share Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EBITDA (Per Share Quarterly) Benchmarks

View EBITDA (Per Share Quarterly) Benchmarks
Start Trial
Insmed, Inc. Upgrade
Pfizer Inc. Upgrade
Biogen, Inc. Upgrade
Bristol Myers Squibb Co. Upgrade
BridgeBio Pharma, Inc. Upgrade